The Latin America, Middle East and Africa Cord Blood Banking Services Market would witness market growth of 19.5% CAGR during the forecast period (2022-2028).
The cord blood that is received by cord blood banks is examined and processed. It gives the blood particular qualities. Characteristics can be attributed to each person's blood and cells. The characteristics of the person receiving the stem cells and the given stem cells must match for the treatment of a disease. A match indicates that these qualities are comparable. When a match has been made, donated stem cells can aid the immune system in fighting diseases in a sick person.
Parents who desire to store their baby's placenta and umbilical cord blood as "insurance" for potential future medical needs have the option of doing so through cord blood banking. It can also be applied to other biologically related kids, whether they are members of their own family or not. Red blood cells, platelets, white blood cells, and plasma are all present in cord blood in the same quantities as in regular blood.
Numerous hospital construction projects are currently in progress in the region. There is competition among the seven Emirates to draw medical tourism, which is driving up demand for contemporary facilities with the newest medical technology. In order to prevent and treat the rising incidence of non-communicable diseases, including cardiovascular diseases, and cancer, the Ministry of Health keeps updating the nation's hospitals with the newest technology. The Dubai Health Authority will keep coordinating medical technology with efforts to build and construct smart cities. The UAE government is relaxing regulations to entice foreign investment and raise industry standards for healthcare.
The Brazil market dominated the LAMEA Cord Blood Banking Services Market by Country in 2021; thereby, achieving a market value of $64.9 million by 2028. The Argentina market is showcasing a CAGR of 20.1% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 19.2% during (2022 - 2028).
Based on Component, the market is segmented into Cord Tissue and Cord Blood. Based on Storage Services, the market is segmented into Private Cord Blood Banks and Public Cord Blood Banks. Based on Application, the market is segmented into Diabetes, Cancer Disease, Blood Disease, Immune Disorders, Metabolic Disorders, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Cord Blood Banking Services Market is Predict to reach $2.9 Billion by 2028, at a CAGR of 13.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AMAG Pharmaceuticals, Inc., Americord Registry LLC, StemCyte, Inc., Cordlife Group Limited, cordvida, Cryo-Cell International, Inc., CryoHoldco de LatinoAmérica and Vita 34 AG
By Component
By Storage Services
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
